Minoryx
Minoryx official website
- Website
- minoryx.com
- Total Funding
- $106.9M
- Last Round
- $59.5M Series CMay 2022
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 12 investors for this company. The full record is or through the API.
About
Minoryx is a biotechnology company developing treatments for rare central-nervous-system diseases, especially neurodegenerative orphan conditions with substantial unmet need. Its lead program, leriglitazone, is a brain-penetrant selective PPAR gamma agonist in clinical development for multiple CNS disorders, including X-linked adrenoleukodystrophy. The company is headquartered in Mataró, Barcelona, and also maintains an R&D site in Gosselies, Belgium.
Summary
Minoryx is a Biotech company. It has raised $106.9M in total across 3 rounds, most recently a $59.5M Series C round in May 2022. Investors include Ysios Capital, Caixa Capital Risc and Fund+.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2022
Sign up to see all 3 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/minoryx"><img src="https://indexed.vc/api/badge/company/minoryx" alt="Minoryx on Indexed.vc" width="260" height="76" /></a>